Pharmaceutical Warnings: A Changing Landscape

By Chris Essig and Schuyler Ferguson (November 9, 2018, 2:46 PM EST) -- Can brand-name drug companies face failure-to-warn lawsuits from patients who take generic versions of their products? If the innovator stops making the drug, but generics continue to sell, is the brand-name manufacturer forever liable? How much control should generic manufacturers have over the drug labels on their products? How should the pharmaceutical industry warn the public of potential side effects when advertising their products directly to consumers?...

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!